Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mycophenolate mofetil in dermatomyositis: is it safe?
Rowin J, Amato AA, Deisher N, Cursio J, Meriggioli MN. Rowin J, et al. Among authors: amato aa. Neurology. 2006 Apr 25;66(8):1245-7. doi: 10.1212/01.wnl.0000208416.32471.c0. Neurology. 2006. PMID: 16636243
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
What determines quality of life in inclusion body myositis?
Sadjadi R, Rose MR; Muscle Study Group. Sadjadi R, et al. J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1164-6. doi: 10.1136/jnnp.2009.183863. Epub 2010 Jul 2. J Neurol Neurosurg Psychiatry. 2010. PMID: 20601666
Inclusion Body Myositis.
Barohn RJ, Amato AA. Barohn RJ, et al. Among authors: amato aa. Curr Treat Options Neurol. 2000 Jan;2(1):7-12. doi: 10.1007/s11940-000-0019-9. Curr Treat Options Neurol. 2000. PMID: 11096732
Chronic Cryptogenic Sensory Polyneuropathy.
Wolfe GI, Barohn RJ, Amato AA. Wolfe GI, et al. Among authors: amato aa. Arch Neurol. 2000 May;57(5):759-760. Arch Neurol. 2000. PMID: 10815151 No abstract available.
TARDBP Mutations in Facial-Onset Sensory and Motor Neuronopathy.
Picher-Martel V, Babu S, Amato AA. Picher-Martel V, et al. Among authors: amato aa. Neurol Genet. 2024 Jun 4;10(3):e200160. doi: 10.1212/NXG.0000000000200160. eCollection 2024 Jun. Neurol Genet. 2024. PMID: 38841627 Free PMC article.
Author Correction: International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-O'Callaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. Oldroyd AGS, et al. Nat Rev Rheumatol. 2024 May;20(5):315. doi: 10.1038/s41584-024-01111-x. Nat Rev Rheumatol. 2024. PMID: 38548933 No abstract available.
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-O'Callaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. Oldroyd AGS, et al. Nat Rev Rheumatol. 2023 Dec;19(12):805-817. doi: 10.1038/s41584-023-01045-w. Epub 2023 Nov 9. Nat Rev Rheumatol. 2023. PMID: 37945774 Review.
277 results